Artificial Intelligence to Measure Adherence to Oral Medication

Description

The aims of this project is to use an artificial intelligence (AI) smartphone app to provide support for medication adherence by patients with first episode psychosis.

Conditions

First Episode Psychosis

Study Overview

Study Details

Study overview

The aims of this project is to use an artificial intelligence (AI) smartphone app to provide support for medication adherence by patients with first episode psychosis.

Early-phase Schizophrenia: Practice-based Research to Improve Outcomes (ESPRITO) - Using Artificial Intelligence to Measure Adherence to Oral Medication

Artificial Intelligence to Measure Adherence to Oral Medication

Condition
First Episode Psychosis
Intervention / Treatment

-

Contacts and Locations

Hialeah

Citrus Health, Hialeah, Florida, United States, 33012

Grand Rapids

InterAct, Grand Rapids, Michigan, United States, 49503

Kalamazoo

InterAct of Michigan, Kalamazoo, Michigan, United States, 49007

Oklahoma City

Red Rock, Oklahoma City, Oklahoma, United States, 73105

Tulsa

Family and Children's Services, Tulsa, Oklahoma, United States, 74315

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Enrolled in a CSC program
  • * Prescribed an oral antipsychotic
  • * none

Ages Eligible for Study

15 Years to 40 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Northwell Health,

Study Record Dates

2024-12-31